NextGen Healthcare - NXGN Stock Forecast, Price & News

NextGen Healthcare, Inc. provides healthcare technology solutions in the United States. The company offers clinical care solutions, including NextGen Enterprise EHR; financial solutions, such as NextGen Enterprise PM; patient engagement solutions comprising NextGen Virtual Visits; integrated clinical care and financial solutions consisting of NextGen Office; interoperability solutions that include NextGen Share and Mirth Connect; data and analytics solutions, which comprise NextGen Health Data Hub; and value based care solutions, including NextGen Population Health Solutions. It also provides managed services, such as revenue cycle management services comprising billing and collections, electronic claims submission and denials management, electronic remittance and payment posting, and accounts receivable follow-up; and client and support services. Further, the company offers professional services consisting of training, project management, installation services, and application managed services; and consulting services that include physician, professional, and technical consulting; assisting clients to optimize their staffing and software solutions; enhancing financial and clinical outcomes; achieving regulatory requirements; and meeting the requirements of healthcare reform. It serves accountable care organizations, independent physician associations, managed service organizations, veterans service organizations, dental service organizations, ambulatory care centers, and community health centers through a direct sales force and reseller channel. The company was formerly known as Quality Systems, Inc. and changed its name to NextGen Healthcare, Inc. in September 2018. NextGen Healthcare, Inc. was incorporated in 1974 and is headquartered in Atlanta, Georgia.

NextGen Healthcare Stock Performance

Shares of NASDAQ:NXGN traded up $0.21 during midday trading on Wednesday, reaching $17.43. The stock had a trading volume of 5,213 shares, compared to its average volume of 382,335. The firm has a market cap of $1.19 billion, a price-to-earnings ratio of 1,723.72 and a beta of 1.07. NextGen Healthcare has a twelve month low of $13.64 and a twelve month high of $21.87. The company's 50 day moving average price is $17.54 and its 200 day moving average price is $18.89.

NextGen Healthcare (NASDAQ:NXGN - Get Rating) last issued its quarterly earnings results on Tuesday, May 17th. The company reported $0.10 earnings per share (EPS) for the quarter, hitting analysts' consensus estimates of $0.10. The firm had revenue of $151.26 million for the quarter, compared to the consensus estimate of $150.07 million. NextGen Healthcare had a negative net margin of 0.01% and a positive return on equity of 8.20%. The company's revenue for the quarter was up 4.9% on a year-over-year basis. During the same quarter in the previous year, the company earned $0.13 EPS. Equities analysts forecast that NextGen Healthcare will post 0.62 earnings per share for the current fiscal year.

Wall Street Analysts Forecast Growth

Separately, Guggenheim upgraded shares of NextGen Healthcare from a "neutral" rating to a "buy" rating and set a $26.00 price target on the stock in a research note on Friday, May 6th.

Insider Activity

In other news, Director Craig A. Barbarosh sold 3,500 shares of NextGen Healthcare stock in a transaction on Friday, July 1st. The shares were sold at an average price of $17.39, for a total value of $60,865.00. Following the completion of the sale, the director now owns 64,183 shares in the company, valued at approximately $1,116,142.37. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this hyperlink. Insiders sold 10,500 shares of company stock worth $185,185 in the last quarter. 4.50% of the stock is owned by corporate insiders.